Can you provide the last earnings date for BIO-TECHNE CORP?
BIO-TECHNE CORP (TECH) last reported earnings on 2/4/2026.
NASDAQ:TECH • US09073M1045
Past quarterly earnings results for BIO-TECHNE CORP (TECH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 0.46 | 0.44 | 3.95% | 9.52% | 295.877M | 295.99M | -0.04% | 0.24% |
| Q1 2026 | 0.42 | 0.43 | -2.04% | - | 286.555M | 297.05M | -3.53% | -1.00% |
| Q4 2025 | 0.53 | 0.51 | 4.14% | 8.16% | 316.964M | 321.91M | -1.54% | 3.55% |
| Q3 2025 | 0.56 | 0.52 | 7.36% | 16.67% | 316.181M | 323.88M | -2.38% | 4.20% |
| Q2 2025 | 0.42 | 0.39 | 6.57% | 5.00% | 295.182M | 291.46M | 1.28% | 8.28% |
| Q1 2025 | 0.42 | 0.39 | 7.75% | 2.44% | 289.458M | 285.86M | 1.26% | 4.52% |
| Q4 2024 | 0.49 | 0.50 | -2.78% | -10.91% | 306.098M | 312.62M | -2.09% | 1.59% |
| Q3 2024 | 0.48 | 0.46 | 3.92% | -9.43% | 303.428M | 298.03M | 1.81% | 3.16% |
| Q2 2024 | 0.40 | 0.42 | -4.95% | -14.89% | 272.598M | 283.08M | -3.70% | 0.37% |
| Q1 2024 | 0.41 | 0.44 | -7.65% | -7.87% | 276.935M | 293.16M | -5.53% | 2.68% |
| Q4 2023 | 0.55 | 0.56 | -1.39% | 7.32% | 301.32M | 313.39M | -3.85% | 4.55% |
| Q3 2023 | 0.53 | 0.54 | -1.60% | -0.93% | 294.146M | 302.59M | -2.79% | 1.29% |
| Q2 2023 | 0.47 | 0.63 | -25.65% | - | 271.6M | 294.57M | -7.80% | 0.85% |
| Q1 2023 | 0.45 | 0.61 | -26.67% | -2.73% | 269.7M | 287.37M | -6.15% | 4.66% |
| Q4 2022 | 0.51 | 0.53 | -3.25% | 9.63% | 288.2M | 292.86M | -1.59% | 11.27% |
| Q3 2022 | 0.54 | 0.51 | 5.04% | 19.55% | 290.4M | 284.86M | 1.94% | 19.21% |
| Q2 2022 | 0.47 | 0.46 | 2.81% | 16.05% | 269.3M | 271.91M | -0.96% | 20.06% |
| Q1 2022 | 0.46 | 0.44 | 4.22% | 27.97% | 257.7M | 257.47M | 0.09% | 26.20% |
| Q4 2021 | 0.47 | 0.43 | 7.77% | 87.00% | 259M | 249.51M | 3.80% | 47.33% |
| Q3 2021 | 0.45 | 0.40 | 13.01% | 28.78% | 243.6M | 232.78M | 4.65% | 25.12% |
| Q2 2021 | 0.41 | 0.35 | 15.92% | 50.00% | 224.3M | 210.63M | 6.49% | 21.31% |
| Q1 2021 | 0.36 | 0.28 | 28.32% | 34.91% | 204.2M | 188.73M | 8.20% | 11.46% |
| Q4 2020 | 0.25 | 0.19 | 30.26% | - | 175.8M | 167.19M | 5.15% | - |
| Q3 2020 | 0.35 | 0.29 | 18.51% | - | 194.7M | 189.14M | 2.94% | - |
| Q2 2020 | 0.27 | 0.29 | -6.29% | - | 184.9M | 195.06M | -5.21% | - |
| Q1 2020 | 0.27 | 0.27 | -1.26% | - | 183.2M | 182.99M | 0.11% | - |
Notes
BIO-TECHNE CORP (TECH) last reported earnings on 2/4/2026.
BIO-TECHNE CORP (TECH) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, BIO-TECHNE CORP (TECH) has beaten EPS estimates in 3 out of 4 releases.